Table 1.

Data required for a multivariate meta-analysis of the 10 hypertension trials.

	Treatment effect estimates (within-study variances)				Within-study correlations
Trial	SBP (1)	DBP (2)	CVD (3)	Stroke (4)	(1)&(2)	(1)&(3)	(1)&(4)	(2)&(3)	(2)&(4)	(3)&(4)
1	−6.66 (0.72)	−2.99 (0.27)	−0.09 (0.17)	−1.91 (1.17)	0.79	0.01	−0.01	−0.02	−0.02	0.16
2	−14.17 (4.73)	−7.87 (1.44)	0.06 (0.13)	−0.15 (0.17)	0.50	0.11	0.10	0.09	0.10	0.64
3	−12.88 (10.31)	−6.01 (1.77)	−0.17 (0.20)	0.75 (0.35)	0.59	−0.21	−0.05	−0.04	−0.04	0.10
4	−8.71 (0.30)	−5.11 (0.10)	−0.24 (0.03)	−0.29 (0.07)	0.77	0.09	0.02	0.13	0.04	0.52
5	−8.70 (0.14)	−4.64 (0.05)	−0.18 (0.03)	−0.41 (0.11)	0.64	0.04	0.04	0.04	0.04	0.42
6	−10.60 (0.58)	−5.56 (0.18)	−0.23 (0.02)	−0.20 (0.03)	0.50	0.00	0.03	−0.02	0.00	0.62
7	−11.36 (0.30)	−3.98 (0.075)	−0.32 (0.02)	−0.45 (0.02)	0.48	−0.01	−0.02	−0.03	−0.03	0.69
8	−17.93 (5.82)	−6.54 (1.31)	−1.87 (1.17)	0.32 (0.83)	0.59	−0.02	−0.07	−0.03	0.00	0.35
9	−6.55 (0.41)	−2.08 (0.11)	−0.33 (0.09)	−0.48 (0.04)	0.45	0.11	0.08	0.03	0.03	0.78
10	−10.26 (0.20)	−3.49 (0.04)	−0.26 (0.03)	−0.55 (0.03)	0.48	0.05	0.04	0.04	0.05	0.62

SBP:systolic blood pressure; SBP: systolic blood pressure; CVD: cardiovascular disease.